Role in inflammatory conditions (e.g., psoriasis, atopic dermatitis, vitiligo, rosacea).Key kinases: JAK, PDGFR, Src family.Potential: JAK inhibitors modulate inflammation, PDGFR/Src inhibitors reduce immune cell activation. This evidence concerns the gene SRC and atopic eczema.